Stock listing
VT6 Stock Price, News, Filings & Events — Voyager Therapeutics, Inc.
Selected listing: VT6 · TRADEGATE · EUR · DE
This page tracks Voyager Therapeutics, Inc.'s VT6:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VT6:TRADEGATE. VT6:TRADEGATE is the stock-level entry point for investors researching Voyager Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- VT6:TRADEGATE
- Asset type
- Stock
- Market cap
- $190.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TRADEGATE
- Currency
- EUR
Voyager Therapeutics, Inc. VT6:TRADEGATE stock context
This page tracks Voyager Therapeutics, Inc.'s VT6:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VT6:TRADEGATE. VT6:TRADEGATE is the stock-level entry point for investors researching Voyager Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Voyager Therapeutics, Inc.
Voyager Technologies, Inc. Announces Proposed Convertible Senior Notes Offering
September 22, 2026
Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026
July 13, 2026
Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026
June 29, 2026
Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference
June 11, 2026
Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease
June 1, 2026
Voyager Therapeutics, Inc. earnings calls
Voyager Therapeutics, Inc. (VYGR) Q3 2025 Earnings Call
November 11, 2025 · Replay with transcript and chapters
Voyager Therapeutics, Inc. (VYGR) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
Voyager Therapeutics, Inc. (VYGR) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Voyager Therapeutics, Inc. (VYGR) Q4 2024 Earnings Call
March 11, 2025 · Replay with transcript and chapters
Voyager Therapeutics, Inc. (VYGR) Q3 2024 Earnings Call
November 12, 2024 · Replay with transcript and chapters
Voyager Therapeutics, Inc. (VYGR) Q2 2024 Earnings Call
August 6, 2024 · Replay with transcript and chapters
Research Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for VT6:TRADEGATE.
Voyager Therapeutics, Inc. company profile
View the public company page for Voyager Therapeutics, Inc. on 6ix.
Voyager Therapeutics, Inc. news
Read company news and market updates connected to Voyager Therapeutics, Inc..
Voyager Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Voyager Therapeutics, Inc..
Alternate listings
VYGR:NASDAQ
US · USD
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VT6:TRADEGATE.
VYGR:BMV
MX · MXN
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VT6:TRADEGATE.
VT6:GETTEX
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VT6:TRADEGATE.
A143XJ:LSX
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VT6:TRADEGATE.
A143XJ:LS
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VT6:TRADEGATE.
VT6:FWB
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VT6:TRADEGATE.
VYGR:BIVA
MX · MXN
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VT6:TRADEGATE.
VYGR:BOATS
US · USD
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VT6:TRADEGATE.
VT6:DUS
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VT6:TRADEGATE.
VT6:HAM
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VT6:TRADEGATE.
VT6:MUN
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VT6:TRADEGATE.
VT6:SWB
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VT6:TRADEGATE.